Connect with us

Health

US doubles spending on potential virus vaccine to nearly US$1 billion – CNA

The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 27) begins the decisive final phase of clinical trials.

Published

on

post featured image
ADVERTISEMENT

WASHINGTON: The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 27) begins the decisive final phase of clinical trials.
The government now plans to spend up to US$472 million on top of the previously announced US$483 million, the Moderna biotechnology company announced Sunday.
Advertisement
Advertisement
Moderna said the added investment was justified by its decision, in…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending